Which injection-site reactions were most commonly reported in Rabipur clinical trials?

In Rabipur clinical trials, the most commonly reported solicited injection-site reactions were pain (30–85%) and induration (15–35%); most injection-site reactions were not severe and resolved within 24–48 hours.